{
    "root": "accd4254-7e75-465a-97fe-1059077c4bb4",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Dicyclomine Hydrochloride",
    "value": "20250319",
    "ingredients": [
        {
            "name": "DICYCLOMINE HYDROCHLORIDE",
            "code": "CQ903KQA31"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "CALCIUM SULFATE, UNSPECIFIED FORM",
            "code": "WAT0DDB505"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FD&C RED NO. 3",
            "code": "PN2ZH5LOQY"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        }
    ],
    "indications": "dicyclomine hydrochloride indicated treatment patients functional bowel/irritable bowel syndrome .",
    "contraindications": "must adjusted individual patient needs .",
    "warningsAndPrecautions": "dicyclomine hydrochloride capsules usp , 10 mg 10 mg blue capsules white powder fill , imprinted logo lannett cap 0586 body , supplied bottles 100 , 500 , 1000 capsules . store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] . dispense well-closed container defined usp . bottles 20 capsules : ndc 68788-8373-2 bottles 30 capsules : ndc 68788-8373-3 bottles 60 capsules : ndc 68788-8373-6 bottles 90 capsules : ndc 68788-8373-9",
    "adverseReactions": "dicyclomine hydrochloride contraindicated infants less 6 months age [ ( 8.4 ) ] , nursing mothers [ ( 8.3 ) ] , patients : •unstable cardiovascular status acute hemorrhage •myasthenia gravis [ ( 5.4 ) ] •glaucoma [ ( 6.3 ) ( 7.1 ) ] •obstructive uropathy [ ( 5.8 ) ] •obstructive disease gastrointestinal tract [ ( 5.5 ) ] •severe ulcerative colitis [ ( 5.7 ) ] •reflux esophagitis",
    "indications_original": "Dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome.",
    "contraindications_original": "Dosage must be adjusted to individual patient needs.",
    "warningsAndPrecautions_original": "Dicyclomine Hydrochloride Capsules USP, 10 mg\n                  \n                  10 mg blue capsules with a white powder fill, imprinted logo LANNETT on the cap and 0586 on the body, supplied in bottles of 100, 500, and 1000 capsules. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a well-closed container as defined in the USP.\n                  Bottles of 20 capsules: NDC 68788-8373-2\n                  Bottles of 30 capsules: NDC 68788-8373-3\n                  Bottles of 60 capsules: NDC 68788-8373-6\n                  Bottles of 90 capsules: NDC 68788-8373-9",
    "adverseReactions_original": "Dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see Use in Specific Populations (8.4)], nursing mothers [see Use in Specific Populations (8.3)], and in patients with:\n                  \n                     \n                        •unstable cardiovascular status in acute hemorrhage\n                     \n                        •myasthenia gravis [see Warnings and Precautions (5.4)]\n                     \n                     \n                        •glaucoma [see Adverse Reactions (6.3) and Drug Interactions (7.1)]\n                     \n                     \n                        •obstructive uropathy [see Warnings and Precautions (5.8)]\n                     \n                     \n                        •obstructive disease of the gastrointestinal tract [see Warnings and Precautions (5.5)]\n                     \n                     \n                        •severe ulcerative colitis [see Warnings and Precautions (5.7)]\n                     \n                     \n                        •reflux esophagitis"
}